Mizuho Reaffirms Outperform on Tesla, $375 Price Target

Jul 24, 2025 Analyst: Vijay Rakesh 1 min read Reproduced verbatim
Rating
Buy
Price target
$375
Implied upside
+13%
vs $332.56 prior close
Mizuho and Tesla logos

Mizuho analyst Vijay Rakesh reiterated an Outperform rating and $375 price target on Tesla (NASDAQ: TSLA)

“TSLA reported inline 2Q25E Rev/EPS of $22.5B/$0.40 (vs. cons. $22.6B/$0.42). Auto GMs ex-ZEV credits better at ~15% vs. cons. ~13.3%, up 250bps q/q.

TSLA did not guide 2025E deliveries noting ‘shifting global trade and fiscal policies’.

2Q25 deliveries were dn ~14% y/y, as we estimate full-year 2025E at dn 11% y/y though 2H25E slightly better with NA test drives up 20% q/q.

TSLA noting EV subsidy end in SepQ could see potential for some ‘rough quarters in 4Q25/1H26E’ with need to drive affordability/sales in the absence of subsidies.

Maintain Outperform, PT $375, adjust estimates, as we see TSLA positioned well to disrupt AV and Robotics despite near-term EV demand headwinds.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+13% TSLA $332.56 → $375 (Oct 9) · target reached

This call✓ Target reached on Sep 12, 2025, 2 months after the note. Same target as this firm’s Jul 7, 2025 note, so it is scored there.

Firm track recordMizuho: 95% of its 20 targets at least a year old were reached within 12 months (#2 of 20 firms); on Tesla, 6 of 6. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.